Novel Vaccine against Chemo-resistant Ovarian Cancer
March 13, 2007 by Gloria Gamat
Filed under Diseases & Conditions
The Cancer Treatment Centers of America is launching a new cancer vaccine therapy that will be offered by the CTCA to chemo-resistant ovarian cancers and to be developed by AVAX Technologies, Inc.
Ovarian cancer is one of the hardest to detect in early stages, a complex cancer that is often resistant to chemotherapy.
The breakthrough treatment method uses the patient’s own tumor tissues to create a patient-specific vaccine and is combined with chemotherapy delivered directly into the abdominal cavity.
Read the full report.
